Subclinical Thyroid Dysfunction and the Risk for Fractures A Systematic Review and Meta-analysis

被引:49
|
作者
Wirth, Christina D.
Blum, Manuel R.
da Costa, Bruno R.
Baumgartner, Christine
Collet, Tinh-Hai
Medici, Marco
Peeters, Robin P.
Aujesky, Drahomir
Bauer, Douglas C.
Rodondi, Nicolas
机构
[1] Univ Bern, Bern, Switzerland
[2] Univ Lausanne Hosp, Lausanne, Switzerland
[3] Erasmus MC, Rotterdam, Netherlands
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
基金
瑞士国家科学基金会;
关键词
BONE-MINERAL DENSITY; CORONARY-HEART-DISEASE; NON-VERTEBRAL FRACTURES; L-THYROXINE TREATMENT; LONG-TERM THYROXINE; BODY-MASS INDEX; FOLLOW-UP; HIP FRACTURE; SERUM TSH; OSTEOPOROTIC FRACTURE;
D O I
10.7326/M14-0125
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Data on the association between subclinical thyroid dysfunction and fractures conflict. Purpose: To assess the risk for hip and nonspine fractures associated with subclinical thyroid dysfunction among prospective cohorts. Data Sources: Search of MEDLINE and EMBASE (1946 to 16 March 2014) and reference lists of retrieved articles without language restriction. Study Selection: Two physicians screened and identified prospective cohorts that measured thyroid function and followed participants to assess fracture outcomes. Data Extraction: One reviewer extracted data using a standardized protocol, and another verified data. Both reviewers independently assessed methodological quality of the studies. Data Synthesis: The 7 population-based cohorts of heterogeneous quality included 50 245 participants with 1966 hip and 3281 nonspine fractures. In random-effects models that included the 5 higher-quality studies, the pooled adjusted hazard ratios (HRs) of participants with subclinical hyperthyroidism versus euthyrodism were 1.38 (95% CI, 0.92 to 2.07) for hip fractures and 1.20 (CI, 0.83 to 1.72) for nonspine fractures without statistical heterogeneity (P = 0.82 and 0.52, respectively; I-2 = 0%). Pooled estimates for the 7 cohorts were 1.26 (CI, 0.96 to 1.65) for hip fractures and 1.16 (CI, 0.95 to 1.42) for nonspine fractures. When thyroxine recipients were excluded, the HRs for participants with subclinical hyperthyroidism were 2.16 (CI, 0.87 to 5.37) for hip fractures and 1.43 (CI, 0.73 to 2.78) for nonspine fractures. For participants with subclinical hypothyroidism, HRs from higher-quality studies were 1.12 (CI, 0.83 to 1.51) for hip fractures and 1.04 (CI, 0.76 to 1.42) for nonspine fractures (P for heterogeneity = 0.69 and 0.88, respectively; I-2 = 0%). Limitations: Selective reporting cannot be excluded. Adjustment for potential common confounders varied and was not adequately done across all studies. Conclusion: Subclinical hyperthyroidism might be associated with an increased risk for hip and nonspine fractures, but additional large, high-quality studies are needed.
引用
收藏
页码:189 / U145
页数:15
相关论文
共 50 条
  • [11] Thyroid dysfunction and risk of different types of dementia: A systematic review and meta-analysis
    Ye, Jianbo
    Huang, Zhenxing
    Liang, Chunfeng
    Yun, Zhang
    Huang, Lili
    Liu, Yuping
    Luo, Zuojie
    MEDICINE, 2024, 103 (34)
  • [12] The Effect of Subclinical Maternal Thyroid Dysfunction and Autoimmunity on Intrauterine Growth Restriction: A Systematic Review and Meta-Analysis
    Zhao Tong
    Zhang Xiaowen
    Chen Baomin
    Liu Aihua
    Zhou Yingying
    Teng Weiping
    Shan Zhongyan
    MEDICINE, 2016, 95 (19)
  • [13] Does thyroid dysfunction increase the risk of breast cancer? A systematic review and meta-analysis
    Fang, Y.
    Yao, L.
    Sun, J.
    Yang, R.
    Chen, Y.
    Tian, J.
    Yang, K.
    Tian, L.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2017, 40 (10) : 1035 - 1047
  • [14] Does thyroid dysfunction increase the risk of breast cancer? A systematic review and meta-analysis
    Y. Fang
    L. Yao
    J. Sun
    R. Yang
    Y. Chen
    J. Tian
    K. Yang
    L. Tian
    Journal of Endocrinological Investigation, 2017, 40 : 1035 - 1047
  • [15] Meta-analysis: Subclinical thyroid dysfunction and the risk for coronary heart disease and mortality
    Ochs, Nicolas
    Auer, Reto
    Bauer, Douglas C.
    Nanchen, David
    Gussekloo, Jacobijn
    Cornuz, Jacques
    Rodondi, Nicolas
    ANNALS OF INTERNAL MEDICINE, 2008, 148 (11) : 832 - U53
  • [16] Thyroid dysfunction and cancer incidence: a systematic review and meta-analysis
    Thi-Van-Trinh Tran
    Kitahara, Cari M.
    de Vathaire, Florent
    Boutron-Ruault, Marie-Christine
    Journy, Neige
    ENDOCRINE-RELATED CANCER, 2020, 27 (04) : 245 - 259
  • [17] The relationship of erectile dysfunction and subclinical cardiovascular disease: A systematic review and meta-analysis
    Osondu, Chukwuemeka U.
    Vo, Bryan
    Oni, Ebenezer T.
    Blaha, Michael J.
    Veledar, Emir
    Feldman, Theodore
    Agatston, Arthur S.
    Nasir, Khurram
    Aneni, Ehimen C.
    VASCULAR MEDICINE, 2018, 23 (01) : 9 - 20
  • [18] THYROID DYSFUNCTION AND THE RISK OF DEMENTIA AND COGNITIVE DECLINE: SYSTEMATIC REVIEW, META-ANALYSIS AND CLINICAL IMPLICATIONS
    Rieben, Carole
    Aubert, Carole E.
    Segna, Daniel
    Da Costa, Bruno
    Baumgartner, Christine
    Collet, Tinh-Hai
    Chaker, Layal
    Almeida, Osvaldo P.
    Hogervorst, Eef
    Trompet, Stella
    Masaki, Kamal
    Mooijaart, Simon P.
    Gussekloo, Jacobijn
    Peeters, Robin P.
    Bauer, Douglas
    Aujesky, Drahomir
    Rodondi, Nicolas
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 : S439 - S440
  • [19] Risk of fractures in primary hyperparathyroidism: a systematic review and meta-analysis
    Ejlsmark-Svensson, H.
    Rolighed, L.
    Harslof, T.
    Rejnmark, L.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (06) : 1053 - 1060
  • [20] Metabolic syndrome and risk of subclinical hypothyroidism: a systematic review and meta-analysis
    Zhong, Lei
    Liu, Shuo
    Yang, Yao
    Xie, Tong
    Liu, Jifeng
    Zhao, Huahui
    Tan, Guang
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15